Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-04-01 Option Award |
2024-04-02 4:34 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
1,358 | $8.1 | 812,682 (Direct) |
View |
2024-01-02 Option Award |
2024-01-03 4:12 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
1,687 | $6.52 | 811,324 (Direct) |
View |
2023-10-02 Option Award |
2023-10-03 4:27 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
6,470 | $1.7 | 809,637 (Direct) |
View |
2023-07-03 Option Award |
2023-07-05 4:24 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
3,887 | $2.83 | 803,167 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:23 pm |
N/A 2033-06-14 |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
26,000 | $0 | 26,000 (Direct) |
View |
2023-04-03 Option Award |
2023-04-04 4:20 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
3,438 | $3.2 | 799,280 (Direct) |
View |
2023-01-03 Option Award |
2023-01-04 4:16 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
1,725 | $6.38 | 795,842 (Direct) |
View |
2022-10-03 Option Award |
2022-10-04 6:06 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
1,265 | $8.69 | 794,117 (Direct) |
View |
2022-07-01 Option Award |
2022-07-05 4:12 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
1,372 | $8.03 | 792,852 (Direct) |
View |
2022-06-22 Option Award |
2022-06-23 4:16 pm |
N/A 2032-06-21 |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
23,500 | $0 | 23,500 (Direct) |
View |
2022-04-04 Option Award |
2022-04-05 4:27 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
379 | $26.46 | 791,480 (Direct) |
View |
2022-01-04 Option Award |
2022-01-18 4:30 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
199 | $31.58 | 791,101 (Direct) |
View |
2021-10-04 Option Award |
2021-10-05 4:55 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
138 | $44.99 | 790,902 (Direct) |
View |
2021-07-02 Option Award |
2021-08-20 4:30 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
157 | $39.72 | 790,764 (Direct) |
View |
2021-03-12 Option Award |
2021-03-16 4:17 pm |
N/A 2031-03-11 |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
41,200 | $0 | 41,200 (Direct) |
View |
Ownership |
2021-03-16 4:15 pm |
N/A N/A |
C4 Therapeutics Inc. | CCCC | Dubin Glenn Director |
0 | $0 | 790,607 (Indirect) |
View |